Larvol Delta - BioPath-Holdings-Announces-Positive-Results-from-Interim-Analysis-of-Phase-2-Clinical-Trial-of-Prexigebersen-in-Acute-Myeloid-Leukemia

prexigebersen (BP1001) - Bio-Path

https://www.globenewswire.com/news-release/2023/08/01/2715632/0/en/Bio-Path-Holdings-Announces-Positive-Results-from-Interim-Analysis-of-Phase-2-Clinical-Trial-of-Prexigebersen-in-Acute-Myeloid-Leukemia.html

Aug 1, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next